+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Allergic Conjunctivitis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Allergic Conjunctivitis Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Wegener's Granulomatosis Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Wegener's Granulomatosis Treatment Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Alopecia Treatment Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Alopecia Treatment Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 133 Pages
  • Global
From
Hyaluronic Acid Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Hyaluronic Acid Market - Forecasts from 2020 to 2025

  • Report
  • September 2020
  • 132 Pages
  • Global
From
Canada Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers - Product Thumbnail Image

Canada Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers

  • Report
  • February 2025
  • 29 Pages
  • Canada
From
Australia Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers - Product Thumbnail Image

Australia Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers

  • Report
  • February 2025
  • 29 Pages
  • Australia
From
India Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers - Product Thumbnail Image

India Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers

  • Report
  • February 2025
  • 31 Pages
  • India
From
Germany Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers - Product Thumbnail Image

Germany Aesthetic Injectables Market Outlook to 2033 - Botulinum Toxin type A, Hyaluronic Acid Fillers and Non Hyaluronic Acid Fillers

  • Report
  • February 2025
  • 29 Pages
  • Germany
From
Celiac Disease: Competitive Landscape - Product Thumbnail Image

Celiac Disease: Competitive Landscape

  • Report
  • August 2024
  • 63 Pages
  • Global
From
Androgenic Alopecia: Competitive Landscape - Product Thumbnail Image

Androgenic Alopecia: Competitive Landscape

  • Report
  • May 2024
  • 72 Pages
  • Global
From
Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033 - Product Thumbnail Image

Spinal Muscular Atrophy: Opportunity Assessment and Forecast 2023-2033

  • Report
  • May 2024
  • 64 Pages
  • Global
From
Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Hyaluronic Acid Fillers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • March 2024
  • 115 Pages
  • Global
From
Gout - Opportunity Assessment and Forecast - Product Thumbnail Image

Gout - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 62 Pages
  • Global
From
Insomnia - Opportunity Assessment and Forecast - Product Thumbnail Image

Insomnia - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 67 Pages
  • Global
From
Gaucher Disease - Opportunity Assessment and Forecast - Product Thumbnail Image

Gaucher Disease - Opportunity Assessment and Forecast

  • Report
  • December 2023
  • 59 Pages
  • Global
From
Crohn's Disease Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Crohn's Disease Epidemiology Analysis and Forecast to 2032

  • Report
  • August 2023
  • 47 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more